Literature DB >> 10391220

Cryptorchidism in mice mutant for Insl3.

S Nef1, L F Parada.   

Abstract

Impaired testicular descent (cryptorchidism) is one of the most frequent congenital abnormalities in humans, involving 2% of male births. Cryptorchidism can result in infertility and increases risk for development of germ-cell tumours. Testicular descent from abdomen to scrotum occurs in two distinct phases: the trans-abdominal phase and the inguino-scrotal phase. Currently, little is known about the factors that regulate the trans-abdominal phase of testicular descent. Leydig insulin-like hormone (Insl3) is a member of the insulin hormone superfamily expressed in the developing testis. We show here that mice mutant for Insl3 are viable, but exhibit bilateral cryptorchidism due to developmental abnormalities of the gubernaculum, resulting in abnormal spermatogenesis and infertility. Female homozygotes have impaired fertility associated with deregulation of the oestrus cycle. These findings reveal roles for Insl3 in the development of the urogenital tract and in female fertility. Insl3 may act as a hormone to regulate the growth and differentiation of the gubernaculum, thereby mediating intra-abdominal testicular descent.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391220     DOI: 10.1038/10364

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  109 in total

1.  Impaired nipple development and parturition in LGR7 knockout mice.

Authors:  Magda A M Krajnc-Franken; Ad J M van Disseldorp; Jasper E Koenders; Sietse Mosselman; Marcel van Duin; Jan A Gossen
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

Review 2.  New Insights into biological roles of relaxin and relaxin-related peptides.

Authors:  Jae-Il Park; Chia Lin Chang; Sheau Yu Teddy Hsu
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

Review 3.  Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.

Authors:  M L Halls; E T van der Westhuizen; R A D Bathgate; R J Summers
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

4.  Effects of methanolic extract of Moringa oleifera leaves on semen and biochemical parameters in cryptorchid rats.

Authors:  Ayobami Oladele Afolabi; Hameed Adeola Aderoju; Isiaka Abdullateef Alagbonsi
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-08-12

5.  Origin of INSL3-mediated testicular descent in therian mammals.

Authors:  Jae-Il Park; Jenia Semyonov; Chia Lin Chang; Wei Yi; Wesley Warren; Sheau Yu Teddy Hsu
Journal:  Genome Res       Date:  2008-05-07       Impact factor: 9.043

Review 6.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

7.  In vitro degradation of insulin-like peptide 3 by insulin-degrading enzyme.

Authors:  Wei-Jie Zhang; Xiao Luo; Zhan-Yun Guo
Journal:  Protein J       Date:  2010-02       Impact factor: 2.371

8.  Functional link between bone morphogenetic proteins and insulin-like peptide 3 signaling in modulating ovarian androgen production.

Authors:  Claire Glister; Leanne Satchell; Ross A D Bathgate; John D Wade; Yanzhenzi Dai; Richard Ivell; Ravinder Anand-Ivell; Raymond J Rodgers; Philip G Knight
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

Review 9.  The organizational hypothesis and final common pathways: Sexual differentiation of the spinal cord and peripheral nervous system.

Authors:  Nancy G Forger
Journal:  Horm Behav       Date:  2009-05       Impact factor: 3.587

Review 10.  The biology of infertility: research advances and clinical challenges.

Authors:  Martin M Matzuk; Dolores J Lamb
Journal:  Nat Med       Date:  2008-11-06       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.